title: Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?
authors.affiliation: Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-city, Nagasaki 852-8588, Japan. Electronic address: kuroshima@nagasaki-u.ac.jp.
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Kuroshima
authors.affiliation: Division of Bioprosthodontics, Niigata University Graduate School of Medical and Dental Sciences, 2-5274 Gakkocho-dori, Chuo-ku, Niigata 951-8514, Japan.
authors.forename: Masaru
authors.initials: M
authors.lastname: Kaku
authors.affiliation: Section of Fixed Partial Prosthodontics, Department of Oral Rehabilitation, Fukuoka Dental College, 15-1 Tamura 2-Chome, Sawara-ku, Fukuoka 814-0193, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Matsuura
authors.affiliation: Section of Implant and Rehabilitative Dentistry, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
authors.forename: Ikiru
authors.initials: I
authors.lastname: Atsuta
authors.affiliation: Section of Implant and Rehabilitative Dentistry, Division of Oral Rehabilitation, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Ayukawa
authors.affiliation: Department of Applied Prosthodontics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki-city, Nagasaki 852-8588, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Sawase
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000209:etiology*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001854:Bone Marrow Cells / Q000378:metabolism; D000069448:Denosumab / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D007568:Jaw; D008264:Macrophages; D051379:Mice; D009000:Monocytes; D011476:Prosthodontics / Q000379:methods* / Q000639:trends*; D053245:RANK Ligand / Q000276:immunology; D000071681:Tartrate-Resistant Acid Phosphatase / Q000378:metabolism
chemical_list: D000911:Antibodies, Monoclonal; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D053245:RANK Ligand; D000069448:Denosumab; C000605510:ACP5 protein, human; D000071681:Tartrate-Resistant Acid Phosphatase
keywords: Bisphosphonate; Denosumab; Medication-related osteonecrosis of the jaw; Prosthodontic treatment; TRAP-positive mononuclear cells